Samir Shah | Global Head, Investor Relations |
Vas Narasimhan | Chief Executive Officer |
Harry Kirsch | Chief Financial Officer |
Marie-France Tschudin | President, Novartis Pharmaceuticals |
Susanne Schaffert | President, Novartis Oncology |
Richard Saynor | Chief Executive Officer, Sandoz |
John Tsai | Head, Global Drug Development & CMO |
Mark Purcell | Morgan Stanley |
Graham Parry | Bank of America |
Andrew Baum | Citi |
Laura Sutcliffe | UBS |
Kerry Holford | Berenberg |
Peter Welford | Jefferies |
Keyur Parekh | Goldman Sachs |
Simon Baker | Redburn |
Florent Cespedes | Societe Generale |
Richard Vosser | JPMorgan |
Jo Walton | Credit Suisse |
Richard Parkes | Exane BNP |
[00:00:01] Good morning and good afternoon and welcome to the Novartis Q3 Twenty twenty results release, conference call and live audio webcast. Please note that during the presentation, all participants will be in a listen only mode and the conference is being recorded after the presentation. There will be an opportunity to ask questions by pressing the star and one at any time during the conference. A recording of the conference call, including the Q&A session, will be available on our website shortly after the call ends. Should anyone need assistance during the conference call, they may signal the operator of depression, Storin Zero, with thoughts.